The estimated Net Worth of Thomas J. Lowery is at least $1.05 Milione dollars as of 21 February 2020. Thomas Lowery owns over 10,000 units of T2 Biosystems Inc stock worth over $172,045 and over the last 10 years he sold TTOO stock worth over $43,342. In addition, he makes $831,751 as Chief Scientific Officer at T2 Biosystems Inc.
Thomas has made over 16 trades of the T2 Biosystems Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 10,000 units of TTOO stock worth $23,000 on 21 February 2020.
The largest trade he's ever made was exercising 138,144 units of T2 Biosystems Inc stock on 18 September 2018 worth over $302,535. On average, Thomas trades about 9,040 units every 63 days since 2015. As of 21 February 2020 he still owns at least 74,802 units of T2 Biosystems Inc stock.
You can see the complete history of Thomas Lowery stock trades at the bottom of the page.
Dr. Thomas J. Lowery Ph.D. serves as Chief Scientific Officer of the Company. He has served as our Chief Scientific Officer since September 2013. Since joining our company in 2007, Dr. Lowery has held various technical leadership roles in the assay, methods, reagents and detector development programs. Prior to joining our company, Dr. Lowery conducted research at the University of California Berkeley focused on developing innovative magnetic resonance based biosensors for molecular imaging. Dr. Lowery received his Ph.D. in chemistry from the University of California, Berkeley and his B.S. in biochemistry from Brigham Young University.
As the Chief Scientific Officer of T2 Biosystems Inc, the total compensation of Thomas Lowery at T2 Biosystems Inc is $831,751. There are 3 executives at T2 Biosystems Inc getting paid more, with John McDonough having the highest compensation of $1,637,480.
Thomas Lowery is 41, he's been the Chief Scientific Officer of T2 Biosystems Inc since 2013. There are 16 older and 1 younger executives at T2 Biosystems Inc. The oldest executive at T2 Biosystems Inc is John Cumming, 74, who is the Lead Independent Director.
Thomas's mailing address filed with the SEC is 101, Hartwell Avenue, Lexington, Middlesex County, Massachusetts, 02421, United States.
Over the last 10 years, insiders at T2 Biosystems Inc have traded over $18,971,153 worth of T2 Biosystems Inc stock and bought 5,875,341 units worth $59,722,018 . The most active insiders traders include Adrian M Jones, Group L.P.Crg Partners Iii ... e Thomas J. Carella. On average, T2 Biosystems Inc executives and independent directors trade stock every 20 days with the average trade being worth of $764,499. The most recent stock trade was executed by John J Iii Sperzel on 24 February 2024, trading 67 units of TTOO stock currently worth $154.
t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
T2 Biosystems Inc executives and other stock owners filed with the SEC include: